InvenireX

BiotechnologySeedNewcastle upon Tyne, UKinvenirex.co.uk

Latest round

Seed

Last raised

Nov 2025

Total raised

$3.2M

Investors

3

About InvenireX

Based in Newcastle Upon Tyne, UK, and founded by Daniel Todd in 2021, InvenireX operates as a biotechnology company, that provides molecular diagnostics services. The company specializes in offering solutions for molecular analysis, at the forefront of scientific innovation. InvenireX offers an artificial intelligence-powered DetectX system, coupled with programmable DNA Nanite technology. This integration enables the ultra-early detection and quantification of individual molecules, disease detection, and environmental monitoring, with unparalleled precision and sensitivity, without the need for purification steps. Its AI-powered DetectX system, empowers researchers, clinicians, and innovators to push the boundaries of personalized medicine and diagnostics.

Who invested in InvenireX

3 investors across 2 rounds

See all investors in InvenireX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Nov 18, 2025

    Amount

    $2.6M

    Investors

    Locked

  2. Seed

    Feb 27, 2024

    Amount

    $0.6M

    Investors

    Locked

Questions about InvenireX

Who invested in InvenireX?

InvenireX has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has InvenireX raised?

InvenireX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did InvenireX last raise money?

InvenireX's most recent round on record is a Seed, in Nov 2025.

What does InvenireX do?

Based in Newcastle Upon Tyne, UK, and founded by Daniel Todd in 2021, InvenireX operates as a biotechnology company, that provides molecular diagnostics services.

Where is InvenireX headquartered?

InvenireX is headquartered in Newcastle upon Tyne, UK.

Which VCs invest in companies like InvenireX?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at InvenireX's stage. Their profiles are linked below.

Raising like InvenireX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.